FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21265611000001108: Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70919101000001118 Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70919201000001113 Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Is a Ferrous calcium citrate 181.5mg tablets true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Has specific active ingredient Ferrous calcium citrate true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Is a Cobaxine true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Has active ingredient Iron agent false Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Has active ingredient Ferrous salt true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) 30 tablet Has AMP True Cobaxine 181.5mg tablets (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start